Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Revisiting use of growth factors in myelodysplastic syndromes

    ... colony-stimulating factor (G-CSF) and recombinant erythropoietin (EPO) has improved symptoms in MDS patients in addition to ...

    Research Article last updated 07/31/2012 - 12:57pm.

  2. Clinical use of erythropoietic stimulating agents in myelodysplastic syndromes

    ... symptoms. For more than 20 years, recombinant human erythropoietin has been available for clinical use, and it has been employed in an attempt to relieve MDS-related anemia. Erythropoietin-alpha, erythropoietin-beta, and more recently darbepoetin have ...

    Research Article last updated 10/31/2011 - 10:51am.

  3. Lenalidomide for treatment of myelodysplastic syndromes: current status and future directions.

    ... . In non-del(5q) patients, lenalidomide enhances erythropoietin receptor signaling. Future directions include use of ...

    Research Article last updated 10/11/2011 - 5:58pm.

  4. Azacitidine in lower-risk myelodysplastic syndromes.

    ... data for azacitidine combination therapy with erythropoietin , granulocyte colony-stimulating factor, and valproic ...

    Research Article last updated 10/11/2011 - 5:58pm.

  5. Durable long-term responses in patients with myelodysplastic syndromes treated with lenalidomide.

    ... despite previous treatment with recombinant erythropoietin . One patient began lenalidomide therapy because of ...

    Research Article last updated 10/11/2011 - 5:58pm.

  6. Weekly standard doses of rh-EPO are highly effective for the treatment of anemic patients with low-intermediate 1 risk myelodysplastic syndromes

    ... For more than 20 years erythropoietin (rHEPO) has largely been used to treat anemia in ...

    Research Article last updated 10/11/2011 - 5:58pm.

  7. A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

    ... with the exception that growth factors (G-CSF, erythropoietin , and TPO) and transfusions are allowed before and during the ...

    Clinical Trial last updated 11/29/2016 - 8:29am.

  8. Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of thrombopoietin receptor agonists in aplastic anemia and myelodysplastic syndromes.

    ... white blood cells, in particular neutrophils, and erythropoietin , to stimulate red blood cell production, have been ...

    Research Review last updated 05/02/2016 - 9:21am.

  9. Growth Factors

    ... Red cell growth factor is called erythropoietin or EPO for short. It is a hormone naturally produced ...

    Topic section last updated 04/06/2016 - 12:37pm.

  10. Epoetin Alfa

    ... bone marrow failure disease patients whose natural erythropoietin levels are low. It is given by injection under the skin ...

    Drug last updated 03/24/2016 - 12:32pm.